Genelux Corporation is a biotechnology company focused on developing innovative gene therapies for cancer treatment

The company specializes in harnessing the power of engineered oncolytic viruses, which are designed to selectively target and destroy cancer cells while stimulating the immune system to recognize and attack tumors. Through its proprietary platform, Genelux aims to provide advanced therapeutic options for patients with various types of cancer, working towards improving outcomes and quality of life.